Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections

Michael Kammüller, Tsen-Fang Tsai, Christopher E M Griffiths, Nidhi Kapoor, Pappachan E Kolattukudy, Dominique Brees, Salah-Dine Chibout, Jorge Safi, Todd Fox

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science